CD80 and adenocarcinoma: Although Ad.IL-7/B7.1 was effective against transplanted subcutaneous TS/A adenocarcinoma, intratumoral co-expression of IL-7 plus B7.1 did not show efficacy against 3-methylcholanthrene (3MC)-induced non-transplanted tumors.